Nike Appoints Pfizer’s David Denton as New CFO

Nike (NKE) announced the appointment of David Denton, former chief financial officer of Pfizer (PFE) and CVS Health (CVS), as its new CFO, replacing Matthew Friend who held the position since 2019. The leadership change comes as Nike seeks to strengthen its financial performance amid challenges in the athletic footwear and apparel market.

Background of David Denton

Denton brings over 30 years of financial experience, having served as CFO of Pfizer from 2021 to 2025 and previously as CFO of CVS Health from 2018 to 2021. He also held senior finance roles at Kimberly-Clark. Denton is known for his expertise in managing the finances of large corporations and improving operational efficiency.

Reasons for the Change

Nike did not specify reasons for Friend's departure, but the change is part of the company's efforts to restructure its leadership team to address weak demand in some markets and increased competition from brands like Adidas and New Balance. The company issued updated guidance alongside the announcement.

Impact on the Company

Denton is expected to bring extensive experience in financial management of multinational companies, which could help Nike improve profit margins and cost management. However, his lack of direct experience in the retail sector may present a learning curve.

Market Reaction

Nike's stock (NKE) did not show significant movement following the announcement, with trading remaining relatively stable. Investors are watching how this change will affect the company's financial strategy going forward.